Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Risk Assessment
Contact Us

Consideration of new approach data and fit for purpose analyses in the ORD toxicity assessment portfolio

On this page:

  • Overview
Invited presentation to 2024 Winter ToxForum meeting.   EPA’s Office of Research and Development (ORD) is advancing their portfolio of human health toxicity assessment products to draw on the range of available toxicity data to inform the myriad public health decisions confronting the Agency and communities. Many environmental chemicals are data poor and lack toxicological data that are traditionally used in the derivation of toxicity values.  As alternative approaches to human health toxicity assessment are developed and implemented, scoping and problem formulation steps are critical to appropriately tailor the assessment product to the decisions being made. Examples, such as the recent ORD Human Health Toxicity Value assessments for Perfluoropropanoic acid (PFPrA) and lithium bis[(trifluoromethyl)sulfonyl]azanide (HQ-115), showcase the importance of integrating considerations of decision context and data availability and quality objectives when selecting an assessment product. Another example, such as Provisional Peer-Reviewed Toxicity Value assessments of data-poor chemicals, that rely on expert driven read-across approaches, showcase the importance of an evolving portfolio of assessment approaches in circumstances of limited data.

Impact/Purpose

EPA’s Office of Research and Development (ORD) is advancing their portfolio of human health toxicity assessment products to draw on the range of available toxicity data to inform the myriad public health decisions confronting the Agency and communities. Many environmental chemicals are data poor and lack toxicological data that are traditionally used in the derivation of toxicity values.  As alternative approaches to human health toxicity assessment are developed and implemented, scoping and problem formulation steps are critical to appropriately tailor the assessment product to the decisions being made. This presentation will highlight important considerations and examples to showcase the importance of integrating considerations of decision context and data availability and quality objectives when selecting an assessment product.

Citation

Owens, E. Consideration of new approach data and fit for purpose analyses in the ORD toxicity assessment portfolio. 2024 Toxicology Forum Winter Meeting, Pentagon City, VA, January 22 - 24, 2024.
  • Risk Assessment Home
  • About Risk Assessment
  • Risk Recent Additions
  • Human Health Risk Assessment
  • Ecological Risk Assessment
  • Risk Advanced Search
    • Risk Publications
  • Risk Assessment Guidance
  • Risk Tools and Databases
  • Superfund Risk Assessment
  • Where you live
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on April 01, 2024
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshots
  • Grants
  • No FEAR Act Data
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Open Government
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions

Follow.